Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Onglyza and the Type 2 Diabetes Approval Path: The Map is Still Sketchy
Onglyza and the Type 2 Diabetes Approval Path: The Map is Still Sketchy
Onglyza and the Type 2 Diabetes Approval Path: The Map is Still Sketchy
Submitted by
admin
on August 19, 2009 - 7:26am
Source:
InVivo
News Tags:
diabetes
Onglyza
Bristol-Myers Squibb
AstraZeneca
Headline:
Onglyza and the Type 2 Diabetes Approval Path: The Map is Still Sketchy
Do Not Allow Advertisers to Use My Personal information
